Organon & Co
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +52.1% | -80.9% | +336.8% | -57.5% | +176.6% | -80.8% | +193.3% | +20.0% | -46.6% | +59.6% | -52.4% | – | |
| – | -1.6% | +8.3% | +1.5% | +4.5% | +11.6% | +9.1% | +6.0% | +3.4% | +160.7% | -64.1% | -199.9% | – | |
| – | +0.0% | -3.7% | +7.7% | -10.7% | +4.0% | -7.7% | -8.3% | +9.1% | -70.8% | +171.4% | -199.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +150.0% | -199.1% | – | – | – | -211.6% | – | – | – | – | -200.0% | – | |
| – | +47.3% | +18.5% | -66.7% | +137.5% | +73.7% | -26.5% | -59.8% | +194.9% | -60.9% | -17.8% | +13.5% | – | |
| – | -54.7% | +18.5% | -52.1% | +63.0% | +294.7% | -41.9% | -77.9% | +202.6% | -43.5% | – | -119.7% | – | |
| – | -1.4% | -4.1% | +12.9% | -6.3% | +0.0% | -4.1% | -85.9% | -70.0% | +33.3% | +25.0% | +20.0% | – | |
| – | +0.0% | +0.0% | +600.0% | -85.7% | +100.0% | -75.0% | +1,100.0% | -91.7% | – | – | – | – | |
| – | – | – | – | – | +0.0% | +50.0% | +6,600.0% | -64.2% | +152.8% | -82.4% | -100.0% | – | |
| – | -1.3% | -3.9% | +81.1% | -41.8% | +5.1% | -8.5% | +197.3% | -65.9% | +146.1% | -79.7% | -68.4% | – | |
| – | +217.0% | -142.3% | – | -54.3% | -249.2% | – | – | +40.4% | -234.2% | – | -97.0% | – | |
| – | +53.4% | -106.3% | – | -78.3% | +296.9% | -108.5% | – | -17.7% | -35.6% | +95.8% | -65.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.